undefined undefined
NaN.000
NaN.00%
Cantor Fitzgerald analyst Sarah James maintains LifeMD (NASDAQ:LFMD) with a Overweight and raises the price target from $13 to $15.
05-09 23:00
LifeMD shares are trading lower following Q1 earnings.
05-09 06:14
LifeMD Expects Q2 Revenue Of $48M-$50M, Est $47.141M
05-09 06:11
LifeMD (NASDAQ:LFMD) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.15) by 106.67 percent. This is a 83.33 percent decrease over earnings of $0.06 per share from the same
05-09 05:43
NEW YORK, May 8, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating LifeMD, Inc. (NASDAQ: LFMD) on behalf of the company's shareholders. The investigation seeks...
05-08 20:45
The EPS range excludes the costs related to the initiation of the LifeMD collaboration and any gains or losses from changes in the market price of the company's LifeMD common stock investment.
04-30 04:45
Analysts have been eager to weigh in on the Healthcare sector with new ratings ...
04-09 21:10
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu,...
03-28 19:08
LifeMD, Inc. 8.875% CUM PFD A (NASDAQ:LFMDP) declares $0.5546/share quarterly dividend, in line with previous. Forward yield 9.86% Payable April 15; for shareholders of record April 5; ex-div April 4....
03-26 20:05
12月31日,Lifemd, Inc.(LFMD.US)公布财报,公告显示公司2023财年净利润为-20.60百万美元,同比增加54.77%;其中营业收入为1...
03-13 07:17